Utilities of Botulinum Toxins in Dermatology and Cosmetology

Clin Cosmet Investig Dermatol. 2021 Sep 21:14:1319-1330. doi: 10.2147/CCID.S332247. eCollection 2021.

Abstract

Botulinum toxin (BoNT) is a neurotoxin produced by the Clostridium botulinum bacterium with a well-known efficacy and safety profile in the focal idiopathic hyperhidrosis treatment. BoNT comprises seven different neurotoxins; however, only toxins A and B are clinically employed. BoNT is lately practiced in off-label therapies for a variety of skin diseases. Scar prevention, hyperhidrosis, rhytides, eccrine nevus, alopecia, psoriasis, Darier disease, bullous skin disease, pompholyx and Raynaud's phenomenon are some of the novel indications for BoNT in cosmetic and notably non-cosmetic aspects of dermatology. To employ BoNT correctly in clinical practice, we must have a thorough understanding of the functional anatomy of the mimetic muscles. An intensive literature search was conducted to update all dermatology-oriented experiments and clinical trials on the described element of BoNT for this general overview of BoNT use in dermatology. This review aims to analyse the role of BoNT in dermatology and cosmetology.

Keywords: BoNT; Clostridium botulinum; botulinum toxin; cosmetology; dermatology; neurotoxin.

Publication types

  • Review

Grants and funding

This article was self-funded, and no other source of funding present.